Michel JanicotChief Development Officer at InteRNA Technologies
Michel holds a Ph.D. degree in Biochemistry (Molecular and Cellular Biology) from University Paris VII (France) and was Postdoctoral Fellow at The Johns Hopkins University (Baltimore, MD. USA). He has over 35 years of professional experience in Oncology preclinical and early clinical pharmaceutical drug development in increasing leadership roles at Rhone-Poulenc Rorer (Sanofi) and Janssen (Johnson & Johnson). Since 2012, Michel is the founder and General Manager of JMi ONConsulting, a consulting firm specialized in providing services and guidances for R&D programs (small molecules and biologicals) in the field of Oncology, Inflammation, Immunology, Fibrosis and Ophthalmology, with strong strategic focus on RNA therapeutics. He is also co-founder and Board member of aPODD, a non-profit foundation focusing on Pediatric Oncology.